Conference Reports for NATAP

The Liver Meeting San Francisco November 2018 Back

The impact of HCV SVR from direct acting antiviral and interferon-based treatments on mortality in a large population based cohort study       Reported by Jules Levin AASLD 2018 Nov 9-13 SF